On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJul 23, 2019 3:08 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://cnw.fm/KZdi0). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under the agreement.…

Continue Reading

TuesdayJul 23, 2019 2:51 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

Continue Reading

TuesdayJul 23, 2019 12:09 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://cnw.fm/WgJ6O). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and…

Continue Reading

TuesdayJul 23, 2019 9:40 am

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Prelaunch of Viva Buds Inc.

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, this morning announced the prelaunch of cannabis delivery service Viva Buds Inc. in the San Fernando Valley in Los Angeles, California, with sign-ups now available on its website. MCOA and Natural Plant Extracts of California (“NPE”) established a joint venture (“JV”) in March to form Viva Buds, sharing the net profits on a 50-50 basis. NPE is responsible for managing all operations relating to distribution, manufacturing and delivery of cannabis products, and MCOA will provide capital, consulting and marketing services. The staff and marketing team of Viva Buds…

Continue Reading

MondayJul 22, 2019 10:31 am

CannabisNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in Applied Cannabis Sciences of New Jersey

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its application in the upcoming New Jersey round of Request for Applications (“RFA”), through which the state will issue 24 new permits comprising of 15 dispensary permits, 5 cultivation permits and 4 vertically integrated permits. "Completing this investment with ACS and being on the ground floor…

Continue Reading

MondayJul 22, 2019 9:40 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces PharmHouse JV’s Receipt of Health Canada Cultivation License

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations in 190,000 sq. ft of licensed nursery infrastructure. In addition, the company plans to ramp up its entire 1.3 million sq. ft of ultramodern greenhouse space before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products, both domestically and internationally, for Canopy Rivers’ ecosystem of partners. "This is a significant corporate milestone for Canopy Rivers. We believe the PharmHouse platform…

Continue Reading

FridayJul 19, 2019 3:44 pm

CannabisNewsBreaks – Hemptown USA Employs Strategic Hemp-Cultivation Methodology to Increase Yields, Lower Costs

Hemptown USA is employing technology to improve hemp cultivation by keeping production costs low and optimizing yields. An article discussing the company reads, “Hemptown employs a ‘soil to oil’ methodology that involves experienced professionals working in a few selected agricultural microclimates across Oregon’s Emerald Triangle, Kentucky and Colorado. In 2018, Hemptown harvested 110,000 pounds of full-spectrum biomass with CBD content of approximately 17% from the Oregon hemp farm. . . . In 2019, the company is scaling up operations to meet the growing market demand for affordable hemp and CBD oil. As per initial estimates, it will cultivate over one…

Continue Reading

FridayJul 19, 2019 2:58 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to provide…

Continue Reading

FridayJul 19, 2019 2:41 pm

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Swiftly Expanding Throughout the US

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a company with roots as a family-run business selling vape pens in Washington state, has transformed into an award-winning cannabis holding company with a multistate portfolio. An article discussing the company reads, “Headquartered in Washington, where it all began, the company is rapidly expanding throughout the United States, reaching first into Oregon, California and Nevada, with its products currently sold in 685 stores across six states, and plans in place to continue expansion into other states throughout the year. The company is focused on organic, bottom-up growth as it cultivates and delivers…

Continue Reading

FridayJul 19, 2019 1:03 pm

CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors

Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://cnw.fm/c6cFk). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the…

Continue Reading

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

Contact us: 303.498.7722